A1RG34:BVMF
Argenx Se Bdr
R$191.57
0.00%
(0.00) 1D
Oct 2, 2:33:37 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Mkt. cap
57.18B
Avg. vol.
53.00
Volume
0.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.56M
No. of employees
2K
Mkt. cap
57.18B
Avg. vol.
53.00
Volume
0.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
4 hours ago
argenx presents Vyvgart data: Goldman lifts argenx stock target to EUR 982.00
The Globe and Mail
·
5 hours ago
10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?
AD HOC NEWS
·
1 day ago
argenx stock falls 1.79 percent as Goldman raises its target
AD HOC NEWS
·
2 days ago
Argenx stock after-hours at EUR 815.70: minus 2.59 percent versus prior close
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr